Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Moebius syndrome (MBS) is characterized by congenital facial and abducens nerve palsies. In a single MBS patient, fine mapping of a complex germline chromothriptic rearrangement revealed truncation of one allele of PLXND1, encoding the plexin-D1 receptor essential for semaphorin signaling, suggesting a role in cranial nerve development (PMID:31033088).
No additional pathogenic PLXND1 variants or familial segregations have been described in larger MBS cohorts, and no functional assays specifically assessing PLXND1 variants in MBS models have been performed. The limited genetic and experimental data thus restrict the clinical validity of PLXND1 in MBS to a “Limited” level.
Key take-home: While a single truncating PLXND1 lesion implicates plexin-D1 in MBS, further replication and functional studies are required before clinical implementation.
Gene–Disease AssociationLimitedSingle proband with truncating PLXND1 variant and no additional supporting cases. Functional EvidenceLimitedNo functional studies in MBS context; pathogenicity inferred only from structural disruption. |